The Fed's preferred inflation gauge, the personal consumption and expenditures index, rose 0.3% from November and 2.6% on an ...

Metsera, a clinical-stage biotechnology firm, debuted on the Nasdaq Global Select Market today. After initially offering its ...

Chip stocks were hammered earlier this week following news that China's DeepSeek had reportedly developed an advanced AI model more cheaply and efficiently than U.S. competitors. While several of the ...

The Personal Consumption Expenditures price index, the Federal Reserve's preferred inflation measure, rose 2.6% in December ...

As Friday afternoon trading kicked off in New York, the Dow Jones Industrial Average was wavering but appeared to be on track for its biggest three-week rise since late 2022. On a weekly basis, the ...

Metsera, along with Maze Therapeutics, gave U.S. health care first-time share sales its best month since October.

The S&P 500 and the Nasdaq rose on Friday, as Apple gained following a strong sales forecast and a reading of the U.S.

Shares of Maze Therapeutics rose nearly 1% in their Nasdaq debut on Friday, valuing the kidney disease drug developer at $690.37 million.

Private equity-backed Infinity Natural Resources was valued at $1.30 billion after shares of the oil and natural gas producer ...

Apple and other big U.S. companies reporting fatter profits than expected are helping stock indexes shave off more of their sharp losses from the start of the week. The S&P ...